Corcept Therapeutics | CORT - Cost Of Sales


Corcept Therapeutics reported $2.54M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 26.22M 4.58M Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
ANI Pharmaceuticals USD 122.88M 6.86M Dec/2025
Ardelyx USD 10.85M 6.87M Dec/2025
Assertio Holdings USD 8.89M 2.29M Jun/2024
Aurora Cannabis CAD 88.61M 30.53M Dec/2025
BioMarin Pharmaceutical USD 161.56M 16.62M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Canopy Growth CAD 53.08M 8.3M Dec/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Esperion Therapeutics USD 27.85M 13.43M Dec/2025
J&J USD 8.07B 103M Mar/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Lexicon Pharmaceuticals USD 201K 191K Dec/2025
Merck USD 3.32B 531M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Novartis USD 3.54B 3M Dec/2025
Novartis USD 3.54B 7M Dec/2025
Omeros USD 33.16M 18.52M Jun/2024
Pacira USD 54.62M 6.02M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Supernus Pharmaceuticals USD 47.53M 4.24M Dec/2025
TG Therapeutics USD 38.14M 10.05M Dec/2025